PATENT CLAIM ANALYSIS

Application Number: 16067141
Application Type: Utility
Filing Date: 2018-06
Publication Date: 2019-01
Patent Classification: ["549", "063000"]

Abstract:
Embodiments of the present invention are directed to small molecule inhibitors of PHGDH. Other embodiments of the present invention relate to methods of treating cancers using the small molecule inhibitors of PHGDH disclosed herein. Still other embodiments of the present invention relate to methods for using the small molecule inhibitors of PHGDH to study serine metabolism.

Claim (Index 20):
A compound of the formula (I), as in  claim 1 , wherein the compound is at least 4-fold, at least 10-fold, or at least 100-fold more selective for PHGDH than other NAD(P) +  dependent dehydrogenases.

Metadata:
- Claim Count in Document: 53.0
- Percentile: 94.0
- Lexical Diversity: 2.10714
- Patent Class: 549.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15705200', '15552442', '10092004', '15313012', '14965549']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.6713330060463388
- 35 USC 102 Novelty (BERT): 0.5063818410350146
- Combined Prediction Score: 0.6548378895452065
- Mean Citation Score: 181.898844
- Max Citation Score: 195.85783
- Similarity Product: 124.02762421996832

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test